Affiliations 

  • 1 Centre for Research in Addiction (CentRenA), University of Sultan Zainal Abidin, Terengganu, Malaysia
  • 2 Faculty of Medicine, City Campus, University of Sultan Zainal Abidin, Terengganu, Malaysia
  • 3 Faculty of Pharmacy, University of Indonesia, Indonesia
  • 4 Academic Unit of Emergency Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
Basic Clin Neurosci, 2020 07 01;11(4):381-388.
PMID: 33613876 DOI: 10.32598/bcn.9.10.485

Abstract

N-Methyl-3, 4-methylenedioxyamphetamine (MDMA), or ecstasy is a recreational drug of abuse. It is a synthetic substance that affects the body's systems, which its mechanism of action and treatment should be more investigated. MDMA provides an immediate enjoyable feeling by stimulating the release of neurotransmitters, such as dopamine and serotonin in the brain. Unfortunately, abnormal regulation of the brain neurotransmitters, as well as the increased oxidative stress causes damage to the brain neurons after the MDMA exposure. Only a few studies have been done regarding its treatment. Thus, the treatment of MDMA complications should be further explored mainly by targeting its mechanism of action in the neurotransmitter systems. Hence, this study presents a short review regarding the recent findings on the role of neurotransmitters to cause MDMA neurotoxicity. The results will be useful for future research in elucidating the potential treatment based on the targeted mechanisms to treat the neurotoxic effects of MDMA.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.